• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/49

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

49 Cards in this Set

  • Front
  • Back
Fibrocystic change of the breast*
Cystic changes of either the glands or duct. This stretches the connective tissue and causes fibrosis.



Most common change in premenopausal woman.




Hormone-mediated, normal variation as a consequence of the estrogen and progesterone levels.




Vague irregularity to breast tissue


"Lumpy breast" in upper outer quadrant


Blue domed cysts




1) Cysts: dilation of lobules. Filled with semi-translucent blue-brown fluid.


2) Fibrosis: cysts rupture release secretory material into stroma and inflame


3) Adenosis: Increased acini per lobule. Normally occurs during pregnancy

Fibrocystic change risk for cancer?*
Classically it's benign.



Fibrosis, cysts, apocrine metaplasia means BENIGN

What breast changes carry increased risk for invasive carcinoma?*
Ductal hyperplasia and sclerosing adenosis (too many glands that are fibrosed) = 2x risk



Atypical hyperplasia = 5x risk




The risk applies to BOTH breasts

Intraductal papilloma pathophysiology*
Within the large duct that goes to the nipple, you can grow a fibrovascular fingerlike projection covered by epithelium.



This papillary lesion often bleeds and produces bloody nipple discharge.




Epithelial cells AND MYOEPITHELIAL CELLS line the papillary projection (myo are absent in papillary carcinoma)




Usually premenopausal women.

Fibroadenoma pathophysiology*
Tumor of fibrous tissue + glands



MC benign neoplasm of breast


MC tumor in premenopausal




Well-circumscribed, mobile, marble-like




Estrogen sensitive (can shrink as menopause occurs)




Benign; no risk for carcinoma

Phyllodes tumor*
Fibroadenoma-like with overgrowth of fibrous component, increased cellularity



Leaf-like projections




Most commonly seen in postmenopausal women




CAN be malignant

Acute Mastitis
First month of breastfeeding.



Local bacterial infenction due to crack and fissures in the nipples.




Breast erythematous, painful, fever often present.




Treat with abx and continued expression of milk from the breast

Squamous Metaplasia of Lactiferous Ducts (Zuska disease, periductal mastitis)
Painful erythematous subareolar mass.



90% are smokers, maybe from a Vitamin A deficiency




Keratizing squamous metaplasia of nipple ducts.


Keratin sheds and plugs ductal, dilation and rupture eventually.




En bloc surgical removal of the involved duct and tract. Plus abx.

Duct Ectasia
Palpable periarolar mass with thick white or green nipple secretions.



50-60yo multiparous women.


Fibrosis scar shows nipple retraction




Not associated with smoking.


Ducts filled with lipid laden macrophages.

Sclerosing adenosis morphology and risk
Increased number of acini compressed and distorted in the central portion.



Stromal fibrosis may completely compress lumens to look like cords of cells (mimicking carcinoma)




2x risk of carcinoma

Complex Sclerosing Lesion morphology
Components of sclerosing adenosis, papillomas, and epithelial hyperplasia.



Radial scar : irregular, looks like invasive carcinoma (central glands surrounded by radiating projections into stroma)

Gynecomastia
Only benign lesion in male breast.



Button-like subareolar enlargement.


Imbalance between estrogens and androgens




Seen a lot in cirrhosis (since estrogen isn't as metabolized)




Also seen in puberty, hyperestrenism, Klinefelter Syndrome (XXY)

Ductal Carcinoma in situ
Malignant proliferation of cells in the duct, hasn't broken through the basement membrane.



Detected as calcification on mammography




Comedo type: high grade cells with necrosis and dystrophic calcification in center of ducts. (kind of looks like a bullseye)

Paget disease of the breast, treatment
DCIS that extends (walks up the duct) up to the skin of the nipple



Nipple ulceration and erythema




Almost always associated with an underlying carcinoma, poorly differentiated




ER- HER2+




Mastectomy is curative in >95% of women

Invasive Ductal Carcinoma, NST
Malignant cells have invaded past the basement membrane



Forms duct-like structures in desmoplastic stroma (connective tissue hooked onto the tumor)




"poorly-defined margins and cuts with gritty sensation. The cut surface is gray, opaque, and slightly depressed. Streaks of gray extend into the surrounding fibroadipose tissue."




Detected by physical exam or mammography




Advanced tumors may result in dimpling of skin or retraction of nipple

Subtypes of Invasive ductal carcinoma
Tubular carcinoma

Mucinous carcinoma


Medullary carcinoma


Inflammatory carcinoma

Tubular carcinoma
Well-differentiated tubules that lack myoepithelial cells



Good prognosis

Inflammatory carcinoma
Inflammed, swollen breast



Carcinoma in dermal lymphatics blocks drainage of the breast




Like mastitis, but much worse.Poor prognosis

Medullary carcinoma
Large, high-grade cells growing in sheets with associated lymphocytes and plasma cells



Most common in 6th decade


Increased in BRCA1 carriers


Usually no hormone receptors


Prognosis slightly better than NST

Lobular carcinoma in situ and treatment
Malignant proliferation of cells in lobules (no invasion of BM)



Discovered incidentally, does not produce mass or calcification.




Dyscohesive cells lack E-cadherin


Mucin positive signet ring positive cells common




Almost always ER/PR +, HER2 -




Often multifocal and bilateral


Treat with tamoxifen

Invasive lobular carcinoma
Tumor of cells that grow along lobules, but invade BM



Invade in a single-file pattern due to lack of E-cadherin




Often involves spread to peritoneum, retroperitoneum, and leptomeninges

TNM staging and prognosis of breast cancer
TNM staging = Tumor size, Node metastases, Metastasis for distant



Metastasis is most important factor




Spread to axillary lymph nodes is most useful factor




Sentinel node biopsy is used to assess those axillary lymph nodes

Predictive factors and treatment of breast cancer
Most important factors are Estrogen receptor, Progesterone Receptor and HER2/neu gene amplification status.



ER and PR (nucleus) are associated with response to tamoxifen (anti estrogen)




HER2/neu (surface receptor) amplification is associated with response to trastuzumab




If they're triple negative (no ER, no PR, no HER2/neu) then they have a very poor prognosis. Won't respond to tamoxifen or trastuzumab.

Hereditary Breast Cancer
10% of breast cancer cases



Multiple first-degree relatives with breast cancer, tumor at an early age, or multiple tumors are signifiers




BRCA1 and BRCA2 are the most important single gene mutations




BRCA1 = breast + ovarian cancer


BRCA2 = breast carcinoma in males

Male Breast Cacner
Subareoloar mass in older male

Highest density underneath the nipple


Usually invasive ductal carcinoma (lobular is rare)




BRCA2 associated


Klinefelter syndrome associated

Most common form of invasive breast cancer?
ER + HER2- (like lobular carcinoma)
Second most common form of invasive breast cancer?
ER ± HER2+
Major type of invasive carcinomas in BRCA1 carriers
ER- HER2-
Nottingham Histologic Grading
Grade I: tubular, uniform nuclei low proliferation



Grade II: tubules + cords, mitotic + moderate pleiomorphism + moderate mitoses




Grade III: ragged nests or solid sheets of cells + enlarged irregular nuclei + high proliferative rate of necrosis

Fat Necrosis
Usually prior history of surgery or trauma



Mass, thickening with retraction or mammographic density or calcification




Acute = hemorrhagic with liquefactive


Few days = proliferating fibroblasts + chronic inflammatory cells


Eventually = scar

Mucinous carcinoma
Subtype of invasive ductal carcinoma



Older women, grows slowly


Tumor is rubbery or soft with pale gray-blue gelatinous cut surface




Tumor cells arranged in clusters and small islands floating in lakes of mucin (colloid)




Prognosis slightly better than NST

Tubular carcinoma
Women in their late 40's



Consists exclusively of well-formed tubules


No myoepithelial cells


Sometimes cribiform pattern

Definition of Sojourn time
Duration between when a lesion can be detected on mammography and when it presents clinically (2 years premenopausal, 1 year postmenopausal)
BIRADS Grade 0
Need Additional Imaging or prior mammograms for comparison
BIRADS Grade 1
Negative - nothing to comment on
BIRADS Grade 2
Benign
BIRADS Grade 3
Probably benign (<2% malignant)



Initial short follow-up suggested

BIRADS Grade 4
Suspicious (2-95% malignant)

Biopsy suggested

BIRADS Grade 5
Highly suggestive of malignancy (>95%)Appropriate action should be taken
BIRADS Grade 6
Known Biopsy - Proven Malignancy
Medication causes of gynecomastia
Spironolactone

Hormones


CimetidineKetoconazole


(Some Hormones Create Knockers)




Digoxin

Intraductal papilloma presentation
Bloody discharge, excessive call growth
Duct ectasia presentation
Blockage of lactiferous ducts

Greenish, sebaceous, or bloody discharge

Galactorrhea presentation
bilateral, milky or clear/white substance
Causes of galactorrhea
Pituitary lesions (microadenoma/macroadenoma)



Antipsychotics that suppress dopamine


Hypothyroidism


Estrogens

Work-up and treatment of galactorrhea
Take history of meds, check breast discharge

Get TSH levels and PRL (fasting)




MRI of sella turcica if PRL > 100


Remove offending agent

Microadenoma vs Macroadenoma and treatment
Microadenoma (<1cm) = bromocriptine or cabergoline, dopamine agonistsMacroadenoma (>1cm) = surgery
Treatment of mastitis
Dicloxacillin
peau d'orange
Inflammatory breast cancer